Los Angeles Capital Management’s Abeona Therapeutics ABEO Stock Holding History

Los Angeles Capital Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,561	Closed	-$150K	–	2325
2026 Q1	$150K	Sell	33,561 -121,425	-78%	-$607K	﹤0.01%	1219
2025 Q4	$787K	Sell	154,986 -52,791	-25%	-$266K	﹤0.01%	728
2025 Q3	$1.1M	Sell	207,777 -60,371	-23%	-$383K	﹤0.01%	679
2025 Q2	$1.52M	Buy	+268,148	New	+$1.53M	0.01%	516
2021 Q3	–	Sell	-3,087	Closed	-$120K	–	1461
2021 Q2	$120K	Sell	3,087 -15,354	-83%	-$626K	﹤0.01%	1507
2021 Q1	$867K	Buy	18,441 +5,215	+39%	+$287K	﹤0.01%	960
2020 Q4	$519K	Buy	13,226 +3,357	+34%	+$114K	﹤0.01%	1192
2020 Q3	$252K	Buy	9,869 +4,031	+69%	+$254K	﹤0.01%	1324
2020 Q2	$425K	Buy	+5,838	New	+$404K	﹤0.01%	1173

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Los Angeles Capital Management's ABEO Position: Q2 2026 in Review

Los Angeles Capital Management sold out of Abeona Therapeutics (ABEO) in Q2 2026, closing a stake of 33,561 shares — an estimated $150K sold.

Los Angeles Capital Management first reported a position in ABEO in Q2 2020 and held it in 9 quarters. The position peaked at $1.52M in Q2 2025. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

Los Angeles Capital Management reported no remaining Abeona Therapeutics position as of Q2 2026 after selling out during the quarter.
Los Angeles Capital Management sold 33,561 Abeona Therapeutics shares in Q2 2026, an estimated $150K.
Los Angeles Capital Management first reported a position in Abeona Therapeutics in Q2 2020 and held it in 9 quarters.
Los Angeles Capital Management's Abeona Therapeutics position peaked at $1.52M in Q2 2025.
126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.